NKTX - Nkarta, Inc.
1.87
0.010 0.535%
Share volume: 342,301
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$1.86
0.01
0.01%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-09-2024 | 08-10-2023 | 11-09-2023 | 11-07-2024 | 05-09-2024 | 08-13-2024 | 11-07-2024 | 03-26-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 34.313 M | 36.858 M | 29.294 M | 31.185 M | 32.762 M | 30.715 M | 33.794 M | 30.923 M | |
| Selling general and admin | 8.178 M | 11.736 M | 7.100 M | 7.863 M | 7.525 M | 7.585 M | 8.544 M | 7.796 M | |
| Research and development | 26.135 M | 25.122 M | 22.194 M | 23.322 M | 25.237 M | 23.130 M | 25.250 M | 23.127 M | |
| Total expenses | 34.313 M | 36.858 M | 29.294 M | 31.185 M | 32.762 M | 30.715 M | 33.794 M | 30.923 M | |
| 7.42% | -20.52% | 6.46% | 5.06% | -6.25% | 10.02% | -8.50% | |||
| Operating income | -34.313 M | -36.858 M | -29.294 M | -31.185 M | -32.762 M | -30.715 M | -33.794 M | -30.923 M | |
| Ebit | -34.280 M | -36.857 M | -29.261 M | -31.210 M | -32.764 M | -30.717 M | -33.797 M | -30.829 M | |
| Pretax income | -30.815 M | -33.287 M | -25.645 M | -27.754 M | -29.518 M | -24.993 M | -28.344 M | -25.935 M | |
| 8.02% | -22.96% | 8.22% | 6.36% | -15.33% | 13.41% | -8.50% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -30.815 M | -33.287 M | -25.645 M | -27.754 M | -29.518 M | -24.993 M | -28.344 M | -25.935 M | |
| -8.02% | 22.96% | -8.22% | -6.36% | 15.33% | -13.41% | 8.50% |
